Recall: D-0107-2027

Class II - Potentially Harmful

Class IIClassification
2026-09-29Initiated
OngoingStatus
Direct RxFirm

Product

Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50

Reason

Subpotent Drug

Distribution

Nationwide within the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.